Key result
Two MB CPK samples at 12 and 24 hours optimize acute myocardial infarction detection.
Observational (n=66)
No
Answers are grounded in this paper and cite their sources.
Demonstrates that serial MB creatine phosphokinase testing at 12 and 24 hours optimizes acute myocardial infarction diagnosis, indicating single early tests cannot rule out heart damage.
Sixty-six patients admitted to the coronary care unit within 12 hours of the onset of symptoms of acute myocardial infarction (AMI) were subjected to blood sampling at one- to two-hour intervals for analysis of creatine phosphokinase (CPK) and lactic dehydrogenase (LDH) enzymes and isoenzymes. Complete MB CPK curves were obtained in 27 patients, and these were analyzed for optimum times for sampling and minimum number of analyses for detection of AMI. The present study indicates that (1) optimum detection of AMI can be achieved by analysis for MB CPK in a minimum of two samples obtained at 12 and 24 hours after onset of symptoms of AMI; (2) negative results of analyses for MB CPK in samples obtained before 12 hours or after 24 hours should not be used to exclude the diagnosis of AMI; and (3) a total CPK value within the normal range is not a reliable screening test to exclude analysis of MB CPK.
No takes yet. Share an insight, caveat, or question.
Robert G. Irvin (1980) conducted an observational in Acute myocardial infarction (AMI) (n=66). Serial blood sampling for MB creatine phosphokinase (CPK) and lactic dehydrogenase (LDH) isoenzymes vs. Total CPK value within the normal range or sampling outside the 12-to-24-hour window was evaluated on Optimum times for sampling and minimum number of analyses for detection of acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: